{"content":"<li class=\"n-box-item date-title\" data-end=\"1475207999\" data-start=\"1475121600\" data-txt=\"Sunday, December 22, 2019\">Thursday, September 29, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3211679\" data-ts=\"1475192778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211679-calampminus-12_6-profits-slide-guidance-looks-light\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp -12.6% as profits slide, guidance looks light</a></h4><ul>   <li>CalAmp (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CAMP\" title=\"CalAmp Corp.\">CAMP</a>) has tumbled in after-hours trade, <font color=\"red\">down 12.6%</font>, after it posted a <a href=\"https://seekingalpha.com/news/3211628-calamp-eps-line-misses-revenue\" target=\"_blank\">steep drop in fiscal Q2 profits</a> and missed revenue expectations along with providing light guidance.</li>    <li>Still, the company is \"seeing some firming of demand and is optimistic that the company will see MRM product revenues begin to improve later this fiscal year and into fiscal 2018.\"</li>    <li>For Q3 it's forecasting revenues of $81M-$87M, light of consensus for $95M, and non-GAAP EPS of $0.24-$0.30 (below expectations for $0.32). It also sees EBITDA coming in at $11M-$14M vs. consensus for $15.3M.</li>    <li>GAAP net income came in at $0.5M, down from a year-ago $3.5M. On a non-GAAP basis, net income was $10.1M vs. a year-ago $9.8M. EBITDA was $12.9M, just short of an expected $13M.</li>    <li>Revenue by segment: Wireless DataCom, $83.8M (up 35.6%); Satellite, $6.67M (down 16.5%). Operating income by segment: Wireless DataCom, $5.04M (down 33.1%); Satellite, $139,000 (down 91%).</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3211679\" data-linked=\"CalAmp -12.6% as profits slide, guidance looks light\" data-tweet=\"$CAMP - CalAmp -12.6% as profits slide, guidance looks light https://seekingalpha.com/news/3211679-calampminus-12_6-profits-slide-guidance-looks-light?source=tweet\" data-url=\"https://seekingalpha.com/news/3211679-calampminus-12_6-profits-slide-guidance-looks-light\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211677\" data-ts=\"1475190602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBSFY\" target=\"_blank\">UBSFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211677-ubisoft-cites-massive-support-shareholders-back-slate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ubisoft cites &#39;massive support&#39; as shareholders back slate</a></h4><ul>   <li>Embattled game maker Ubisoft (<a href=\"https://seekingalpha.com/symbol/UBSFY\" title=\"UbiSoft Entertainment Inc. ADR\">OTCPK:UBSFY</a> <font color=\"red\">-1.7%</font>) and its founding Guillemot family have <a href=\"https://www.ubisoftgroup.com/comsite_common/en-US/images/pressrelease_downloadablemm_20160929_052711_r%C3%A9sultatsag2016_eng_tcm99-269320_tcm99-196733-32.pdf\" target=\"_blank\">claimed a win</a> as they try to fight off a hostile takeover by French media giant Vivendi (<a href=\"https://seekingalpha.com/symbol/VIVHY\" title=\"Vivendi SA ADR\">OTCPK:VIVHY</a> <font color=\"red\">-0.5%</font>), saying that today's annual meeting resulted in Ubisoft's slate being elected.</li>    <li>\"The shareholders expressed massive support for the strategy and the management of Ubisoft,\" the company said. Shareholders re-elected Yves Guillemot and Gerard Guillemot as directors, and approved the appointment of two new independent directors, Frédérique Dame and Florence Naviner.</li>    <li>Shareholders also approved officer compensation. The board comprises 10 members (five independent directors).</li>\n<li>Earlier, Vivendi -- which has been steadily building a stake in Ubisoft -- said it didn't intend to seek board seats just yet.</li>    <li>Some resolutions were rejected in the extraordinary portion, the company says, \"due to Vivendi\u2019s systematic obstruction, impeding the proper functioning of the Company, in particular regarding its competitive compensation policy for its talents.\"</li>    <li>Today in Paris, Ubisoft shares <font color=\"red\">slipped 1.2%</font>; Vivendi <font color=\"green\">gained 0.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211677\" data-linked=\"Ubisoft cites &#39;massive support&#39; as shareholders back slate\" data-tweet=\"$UBSFY $UBSFY $VIVHY - Ubisoft cites &#39;massive support&#39; as shareholders back slate https://seekingalpha.com/news/3211677-ubisoft-cites-massive-support-shareholders-back-slate?source=tweet\" data-url=\"https://seekingalpha.com/news/3211677-ubisoft-cites-massive-support-shareholders-back-slate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211676\" data-ts=\"1475189685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MENT\" target=\"_blank\">MENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211676-elliott-management-discloses-8_1-active-stake-in-mentor-graphics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott Management discloses 8.1% active stake in Mentor Graphics</a></h4><ul>     <li>Mentor Graphics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MENT\" title=\"Mentor Graphics Corporation\">MENT</a>) <font color=\"green\">+5.6%</font> AH following Elliott Management's <a href=\"https://www.sec.gov/Archives/edgar/data/701811/000101359416001233/mentor13d-092916.htm\" target=\"_blank\">disclosure</a> that it has <a href=\"http://www.bloomberg.com/news/articles/2016-09-29/elliott-discloses-8-1-activist-stake-in-mentor-graphics\" target=\"_blank\">doubled its stake</a> in the company to 8.1%, saying the stock is \"deeply undervalued.\"</li>     <li>The hedge fund, run by Paul Singer, cites \"numerous operational opportunities, including enhancing operational efficiency and revenue quality, as well as strategic opportunities\u201d that would improve shareholder value.</li>     <li>In June, Elliott reported a 4% stake, in MENT which represented ~4.34M shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211676\" data-linked=\"Elliott Management discloses 8.1% active stake in Mentor Graphics\" data-tweet=\"$MENT - Elliott Management discloses 8.1% active stake in Mentor Graphics https://seekingalpha.com/news/3211676-elliott-management-discloses-8_1-active-stake-in-mentor-graphics?source=tweet\" data-url=\"https://seekingalpha.com/news/3211676-elliott-management-discloses-8_1-active-stake-in-mentor-graphics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211675\" data-ts=\"1475189604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211675-threshold-pharmaceuticalsminus-67_8-cancer-studies-fail-goals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Threshold Pharmaceuticals -67.8% as cancer studies fail goals</a></h4><ul>   <li>Threshold Pharmaceuticals (THLD) has <font color=\"red\">tumbled 67.8%</font> after hours after the company published interim results from its tarloxotinib program that disappointed, and plans to discontinue that program and focus on earlier-stage opportunities.</li>    <li>While the trial achieved the primary interim response rate endpoint in patients with recurrent or metastatic squamous cell carcinoma of the skin, it didn't achieve it in patients with metastatic squamous cell carcinoma of the head and neck, or with advanced EGFR-mutant, T790M-negative non-small cell lung cancer.</li>    <li>The company will focus on evofosfamide, in work at the University of Texas' MD Anderson Cancer Center, as well as an earlier-stage candidate, TH-3424.</li>    <li>The company will provide more operational guidance in Q4.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211675\" data-linked=\"Threshold Pharmaceuticals -67.8% as cancer studies fail goals\" data-tweet=\"$MTEM - Threshold Pharmaceuticals -67.8% as cancer studies fail goals https://seekingalpha.com/news/3211675-threshold-pharmaceuticalsminus-67_8-cancer-studies-fail-goals?source=tweet\" data-url=\"https://seekingalpha.com/news/3211675-threshold-pharmaceuticalsminus-67_8-cancer-studies-fail-goals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211674\" data-ts=\"1475189415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211674-aurinias-voclosporin-successful-in-mid-stage-study-in-lupus-nephritis-shares-ahead-14-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia&#39;s voclosporin successful in mid-stage study in lupus nephritis; shares ahead 14% after hours</a></h4><ul>\n<li>Nano cap Aurinia Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AUPH\" title=\"Aurinia Pharmaceuticals Inc.\">AUPH</a>) is up <font color=\"green\">14%</font> after hours on robust volume in response to its announcement of positive results from a Phase 2b clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02141672?term=aura-lv&amp;rank=1\" target=\"_blank\">AURA-LV</a>, assessing voclosporin for the treatment of <a href=\"http://emedicine.medscape.com/article/330369-overview\" target=\"_blank\">lupus nephritis</a> (LN), inflammation of the kidney caused by systemic lupus erythematosus. The data are a follow-up to the results reported last month.</li>\n<li>In addition to voclosporin achieving its primary endpoint of a statistically valid proportion of subjects achieving complete remission at Week 24, both doses of voclosporin, when added to mycophenolate mofetil [Roche's (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>) CellCept] and a forced oral corticosteroid taper, met all Week 24 secondary endpoints compared to control.</li>\n<li>AURA-LV remains ongoing to its Week 48 endpoint. Relevant data will be analyzed and presented early next year.</li>\n<li>Shares plummeted ~50% in mid-August after the company disclosed that 13 study participants had died, although none were attributed to treatment with voclosporin.</li>\n<li>\n<a href=\"http://www.auriniapharma.com/dnn/ProductsInDevelopment/Voclosporin/WhatisVoclosporin.aspx\" target=\"_blank\">Voclosporin </a>suppresses the immune system by inhibiting an enzyme called <a href=\"https://en.wikipedia.org/wiki/Calcineurin\" target=\"_blank\">calcineurin</a>, which activates T cells. Its value proposition is similar effectiveness to other calcineurin inhibitors (cyclosporin and tacrolimus) without the deleterious side effects.</li>\n<li>Management will host a conference call tomorrow morning, September 30, at 8:00 am ET to discuss the results, including safety data.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3203240-aurinia-pharmas-lead-product-candidate-successful-mid-stage-stage-study-shares-jump-17\" target=\"_blank\">Aurinia Pharma's lead product candidate successful in mid-stage stage study; shares jump 17% premarket</a> (Aug. 15)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211674\" data-linked=\"Aurinia&#39;s voclosporin successful in mid-stage study in lupus nephritis; shares ahead 14% after hours\" data-tweet=\"$AUPH $AUPH $RHHBY - Aurinia&#39;s voclosporin successful in mid-stage study in lupus nephritis; shares ahead 14% after hours https://seekingalpha.com/news/3211674-aurinias-voclosporin-successful-in-mid-stage-study-in-lupus-nephritis-shares-ahead-14-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3211674-aurinias-voclosporin-successful-in-mid-stage-study-in-lupus-nephritis-shares-ahead-14-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211671\" data-ts=\"1475188034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211671-cbs-merger-talk-creates-big-demand-for-viacom-bonds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS merger talk creates big demand for Viacom bonds</a></h4><ul>   <li>Talk of re-merging with CBS (<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> <font color=\"green\">+0.8%</font>) has proved a boon at least for <a href=\"https://seekingalpha.com/news/3210853-ifr-downgrade-viacom-preparing-new-bond-offering\" target=\"_blank\">bonds issued by Viacom</a> (<a href=\"https://seekingalpha.com/symbol/VIA\" title=\"Viacom Inc.\">VIA</a> <font color=\"green\">+3.9%</font>, <a href=\"https://seekingalpha.com/symbol/VIAB\" title=\"Viacom Inc.\">VIAB</a> <font color=\"green\">+3.3%</font>).</li>    <li>Speculation about a combination <a href=\"http://www.reuters.com/article/viacom-cbs-corp-bonds-idUSL2N1C51L0\" target=\"_blank\">drove billions of orders</a> into a $1.3B offering that ended up with an $11B order book. \"If Viacom and CBS do merge, spreads could tighten in another 20bp,\" an investor told IFR.</li>    <li>Meanwhile, despite a Moody's downgrade this month, the ratings agency says that combining with CBS might result in a <a href=\"https://www.moodys.com/research/Moodys-says-that-possible-re-combination-of-Viacom-Baa3-stable--PR_355878?WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20160929_PR_355878\" target=\"_blank\">return to Baa2 ratings</a> for Viacom.</li>    <li>\"The merged entity would benefit under Moonves' stewardship and success in programming networks, as well as from significant cost and revenue synergies,\" Moody's says.</li>    <li>The agency had said that \"with a pro forma revenue base of $27 billion, a merger would significantly increase the companies' scale and strengthen their negotiating power with pay-TV distributors, suppliers and advertisers. The merged entity's larger scale, strengthened market position and expected higher free cash flows would allow for greater capacity to carry debt on the balance sheet.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211671\" data-linked=\"CBS merger talk creates big demand for Viacom bonds\" data-tweet=\"$VIA $VIA $VIAB - CBS merger talk creates big demand for Viacom bonds https://seekingalpha.com/news/3211671-cbs-merger-talk-creates-big-demand-for-viacom-bonds?source=tweet\" data-url=\"https://seekingalpha.com/news/3211671-cbs-merger-talk-creates-big-demand-for-viacom-bonds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211668\" data-ts=\"1475186901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211668-frontier-job-cuts-mainly-skipping-research-triangle-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier job cuts mainly skipping Research Triangle center</a></h4><ul>   <li>Frontier Communications (<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-2.1%</font>) has cut 250 management jobs around the country, though the move <a href=\"http://www.bizjournals.com/triangle/news/2016/09/29/frontier-communications-layoffs-north-carolina.html\" target=\"_blank\">shouldn't affect a planned major expansion</a> in Durham, N.C.</li>    <li>The company had announced an expansion with 200 new jobs as part of its acquisition of Verizon assets in California, Texas and Florida, and planned a support center for Durham -- where the company was the first to offer residential fiber Internet.</li>    <li>While the company employed 250 jobs in North Carolina at the time it announced its expansion, it now says it employs 500 there.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211668\" data-linked=\"Frontier job cuts mainly skipping Research Triangle center\" data-tweet=\"$FTR - Frontier job cuts mainly skipping Research Triangle center https://seekingalpha.com/news/3211668-frontier-job-cuts-mainly-skipping-research-triangle-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3211668-frontier-job-cuts-mainly-skipping-research-triangle-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211663\" data-ts=\"1475184954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211663-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/MENT\" title=\"Mentor Graphics Corporation\">MENT</a> <font color=\"green\">+6.0%</font>. <a href=\"https://seekingalpha.com/symbol/PETX\" title=\"Aratana Therapeutics\">PETX</a> <font color=\"green\">+4.8%</font>. <a href=\"https://seekingalpha.com/symbol/RBS\" title=\"The Royal Bank of Scotland Group plc\">RBS</a> <font color=\"green\">+4.6%</font>. <a href=\"https://seekingalpha.com/symbol/PIR\" title=\"Pier 1 Imports Inc.\">PIR</a> <font color=\"green\">+4.5%</font>. <a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a> <font color=\"green\">+4.3%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/CAMP\" title=\"CalAmp Corp.\">CAMP</a> <font color=\"red\">-12.2%</font>. <a href=\"https://seekingalpha.com/symbol/TWI\" title=\"Titan International Inc.\">TWI</a> <font color=\"red\">-6.0%</font>. <a href=\"https://seekingalpha.com/symbol/ABUS\" title=\"Arbutus Biopharma Corp\">ABUS</a> <font color=\"red\">-4.4%</font>. <a href=\"https://seekingalpha.com/symbol/MRC\" title=\"MRC Global\">MRC</a> <font color=\"red\">-3.6%</font>. <a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"red\">-3.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211663\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MENT $PETX $RBS - After Hours Gainers / Losers https://seekingalpha.com/news/3211663-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3211663-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211660\" data-ts=\"1475183670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHSDF\" target=\"_blank\">MHSDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211660-six-televisa-channels-depart-mexicos-megacable\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Six Televisa channels depart Mexico&#39;s Megacable</a></h4><ul>   <li>Mexico's Megacable (<a href=\"https://seekingalpha.com/symbol/MHSDF\" title=\"Megacable Holdings SAB DE CV\">OTCPK:MHSDF</a>) says it <a href=\"http://www.reuters.com/article/televisa-megacable-idUSL2N1C5236\" target=\"_blank\">won't carry six (more)</a> Grupo Televisa (<a href=\"https://seekingalpha.com/symbol/TV\" title=\"Grupo Televisa, S.A.\">TV</a> <font color=\"red\">-2.2%</font>) channels, after Televisa canceled the deal between the two.</li>    <li>That follows a move in early September by Megacable to drop 14 networks programmed by Televisa. To fill that space, Turner's (NYSE:<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a>) Mexico operation stepped up to provide CNN en Español for Megacable's basic package.</li>    <li>Televisa's top networks, Las Estrellas and Canal 5, had continued to air after that move, as well as Gala TV and Foro TV regionally.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211660\" data-linked=\"Six Televisa channels depart Mexico&#39;s Megacable\" data-tweet=\"$MHSDF $MHSDF $TWX - Six Televisa channels depart Mexico&#39;s Megacable https://seekingalpha.com/news/3211660-six-televisa-channels-depart-mexicos-megacable?source=tweet\" data-url=\"https://seekingalpha.com/news/3211660-six-televisa-channels-depart-mexicos-megacable\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211647\" data-ts=\"1475181587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAY\" target=\"_blank\">STAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211647-extended-stay-backers-cashing-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Extended Stay backers cashing in</a></h4><ul>\n<li>The company launches a 13M paired shares secondary offering of stock by Centerbridge Partners, Paulson &amp; Co., and Blackstone. <a href=\"https://seekingalpha.com/symbol/STAY\" title=\"Extended Stay America, Inc.\">STAY</a> will receive no proceeds from the sale.</li>\n<li>Alongside, the company and its manager will buy back 1.95M shares directly from the seller at whatever price the underwriter (Goldman) receives.</li>\n<li>Shares <font color=\"red\">-2.3%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211647\" data-linked=\"Extended Stay backers cashing in\" data-tweet=\"$STAY - Extended Stay backers cashing in https://seekingalpha.com/news/3211647-extended-stay-backers-cashing-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3211647-extended-stay-backers-cashing-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211636\" data-ts=\"1475180511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211636-immunogen-to-cut-17-of-workforce-after-strategic-review-shares-off-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen to cut 17% of workforce after strategic review; shares off 4% after hours</a></h4><ul>\n<li>Micro cap ImmunoGen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a>) eases <font color=\"red\">4%</font> after hours, albeit on turnover of only 440 shares, following its announcement that it has completed a strategic review of its business. As a result, it will trim its workforce by 17% (65 positions) and seek a development partner for its non-core B-cell lymphoma programs. The company says the move will save $11M in annual operating costs. Most of the cuts will come from Technical Operations and G&amp;A functions.</li>\n<li>The savings will enable it to fund operations into mid-2018 and through the interim analysis of its pivotal study of mirvetuximab soravtansine.</li>\n<li>Management will host a conference call at 4:30 pm ET to discuss its plans.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211636\" data-linked=\"ImmunoGen to cut 17% of workforce after strategic review; shares off 4% after hours\" data-tweet=\"$IMGN - ImmunoGen to cut 17% of workforce after strategic review; shares off 4% after hours https://seekingalpha.com/news/3211636-immunogen-to-cut-17-of-workforce-after-strategic-review-shares-off-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3211636-immunogen-to-cut-17-of-workforce-after-strategic-review-shares-off-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211631\" data-ts=\"1475180346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GS\" target=\"_blank\">GS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211631-reuters-two-groups-to-bid-for-cabelas-this-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Two groups to bid for Cabela&#39;s this week</a></h4><ul>\n<li>Privately-held Bass Pro Shops is partnering with the private-equity arm of Goldman Sachs (NYSE:<a href=\"https://seekingalpha.com/symbol/GS\" title=\"Goldman Sachs Group Inc.\">GS</a>), and they're working on a bid with Capital One (NYSE:<a href=\"https://seekingalpha.com/symbol/COF\" title=\"Capital One Financial Corporation\">COF</a>), which is interested in Cabela's (NYSE:<a href=\"https://seekingalpha.com/symbol/CAB\" title=\"Cabela's Incorporated\">CAB</a>) credit card business, <a href=\"http://www.reuters.com/article/us-cabela-s-m-a-idUSKCN11Z2RL\" target=\"_blank\">according to Reuters' sources</a>.</li>\n<li>Then there's P-E outfit Sycamore Partners which is pairing with Synchrony Financial (NYSE:<a href=\"https://seekingalpha.com/symbol/SYF\" title=\"Synchrony Financial\">SYF</a>) to make an offer.</li>\n<li>Binding bids are due this week.</li>\n<li>Cabela's credit card business is called World's Foremost Bank, and it had nearly 2M accounts, $5B in loans, and $502M in revenue last year.</li>\n<li>Cabela's closed the session <font color=\"green\">higher by 2.3%</font>, with all of that gain coming in the last few minutes as this report hit the wires.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211631\" data-linked=\"Reuters: Two groups to bid for Cabela&#39;s this week\" data-tweet=\"$GS $GS $COF - Reuters: Two groups to bid for Cabela&#39;s this week https://seekingalpha.com/news/3211631-reuters-two-groups-to-bid-for-cabelas-this-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3211631-reuters-two-groups-to-bid-for-cabelas-this-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211621\" data-ts=\"1475178880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEF\" target=\"_blank\">TEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211621-telefonica-cancels-struggling-ipo-for-telxius-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telefonica cancels struggling IPO for Telxius unit</a></h4><ul>   <li>Telefonica (<a href=\"https://seekingalpha.com/symbol/TEF\" title=\"Telefonica S.A.\">TEF</a> <font color=\"red\">-2.2%</font>) has <a href=\"http://www.bloomberg.com/news/articles/2016-09-29/telefonica-cancels-telxius-ipo-due-to-inadequate-market-demand\" target=\"_blank\">canceled its initial public offering</a> for infrastructure unit Telxius, originally set to price today, amid weak demand.</li>    <li>The earlier price range set for the offering had disappointed the debt-heavy carrier and a postponement <a href=\"https://seekingalpha.com/news/3211549-bloomberg-telefonica-nears-postponement-telxius-ipo\" target=\"_blank\">seemed likely earlier today</a>.</li>    <li>The company says it will continue to \"analyze strategic alternatives\" for the division.</li>    <li>Telxius originally looked to take advantage of a wave of cell-tower spin-offs over the past year, including Cellnex and Inwit, but it drew criticism for <a href=\"https://seekingalpha.com/news/3209974-telefonica-prices-telxius-ipo-lower-valuation-hoped\" target=\"_blank\">including undersea cables</a> in the unit, considered a drag on its overall value.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211621\" data-linked=\"Telefonica cancels struggling IPO for Telxius unit\" data-tweet=\"$TEF - Telefonica cancels struggling IPO for Telxius unit https://seekingalpha.com/news/3211621-telefonica-cancels-struggling-ipo-for-telxius-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3211621-telefonica-cancels-struggling-ipo-for-telxius-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211617\" data-ts=\"1475177728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211617-gundlach-stay-away-from-difficult-deutsche-bank-sharesminus-6_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gundlach: &#39;Stay away&#39; from difficult Deutsche Bank; shares -6.5%</a></h4><ul>     <li>Deutsche Bank's (<a href=\"https://seekingalpha.com/symbol/DB\" title=\"Deutsche Bank AG\">DB</a> <font color=\"red\">-6.5%</font>) steep tumble has stabilized a bit over the past couple of hours, but DoubleLine bond guru Jeffrey Gundlach says it's got a ways left to go and to <a href=\"https://twitter.com/CNBCnow/status/781574949567856640\" target=\"_blank\">stay away</a>.</li>     <li>The company is hard to analyze and the prospect of a government bailout, he tells Reuters. The market sell-off \"doesn't feel like\" it's over by any means.</li>     <li>\"The market is going to <a href=\"https://twitter.com/jennablan/status/781577217230802944\" target=\"_blank\">push down Deutsche Bank</a> until there is some recognition of support,\" he says.</li>   <li>Elsewhere in sliding financials today: <a href=\"https://seekingalpha.com/symbol/BAC\" title=\"Bank of America Corporation\">BAC</a> <font color=\"red\">-1.1%</font>; <a href=\"https://seekingalpha.com/symbol/C\" title=\"Citigroup Inc.\">C</a> <font color=\"red\">-2.1%</font>; <a href=\"https://seekingalpha.com/symbol/JPM\" title=\"JPMorgan Chase &amp; Co.\">JPM</a> <font color=\"red\">-1.4%</font>; <a href=\"https://seekingalpha.com/symbol/GS\" title=\"Goldman Sachs Group Inc.\">GS</a> <font color=\"red\">-2.7%</font>; <a href=\"https://seekingalpha.com/symbol/MS\" title=\"Morgan Stanley\">MS</a> <font color=\"red\">-2.2%</font>; <a href=\"https://seekingalpha.com/symbol/SCGLY\" title=\"Societe Generale ADR\">OTCPK:SCGLY</a> <font color=\"red\">-3.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211617\" data-linked=\"Gundlach: &#39;Stay away&#39; from difficult Deutsche Bank; shares -6.5%\" data-tweet=\"$BAC $BAC $C - Gundlach: &#39;Stay away&#39; from difficult Deutsche Bank; shares -6.5% https://seekingalpha.com/news/3211617-gundlach-stay-away-from-difficult-deutsche-bank-sharesminus-6_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3211617-gundlach-stay-away-from-difficult-deutsche-bank-sharesminus-6_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211613\" data-ts=\"1475175949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCEI\" target=\"_blank\">BCEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211613-bonanza-creek-rex-energy-raised-to-hold-from-sell-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bonanza Creek, Rex Energy raised to Hold from Sell at Stifel</a></h4><ul>     <li>Bonanza Creek Energy (<a href=\"https://seekingalpha.com/symbol/BCEI\" title=\"Bonanza Creek Energy\">BCEI</a> <font color=\"red\">-4.7%</font>) and Rex Energy (<a href=\"https://seekingalpha.com/symbol/REXX\" title=\"Rex Energy Corporation\">REXX</a> <font color=\"green\">+8%</font>) are upgraded (<a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Stifel+Upgrades+Bonanza+Creek+Energy+%28BCEI%29+to+Hold/12082766.html\" target=\"_blank\">I</a>, <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Stifel+Upgrades+REX+Energy+%28REXX%29+to+Hold/12082762.html\" target=\"_blank\">II</a>) to Hold from Sell with respective $0.52 and $1 price targets at Stifel, which has an improved oil price outlook following yesterday's OPEC production agreement.</li>     <li>While a formal OPEC agreement that meaningfully reduces supply and record global inventories is far from concrete, a change in Saudi policy - whether perceived or real - and positive commentary from leading OPEC officials appear to be building an oil price floor of $40.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211613\" data-linked=\"Bonanza Creek, Rex Energy raised to Hold from Sell at Stifel\" data-tweet=\"$BCEI $BCEI $REXX - Bonanza Creek, Rex Energy raised to Hold from Sell at Stifel https://seekingalpha.com/news/3211613-bonanza-creek-rex-energy-raised-to-hold-from-sell-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3211613-bonanza-creek-rex-energy-raised-to-hold-from-sell-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211610\" data-ts=\"1475175610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211610-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MIME' title='Mimecast'>MIME</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NMBL' title='Nimble Storage, Inc.'>NMBL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='red'>-10%</font>. SONS <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211610\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$NXPI $MIME $IDT - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3211610-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3211610-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211608\" data-ts=\"1475175103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OZM\" target=\"_blank\">OZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211608-och-ziff-to-pay-413m-over-africa-bribe-charges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Och-Ziff to pay $413M over Africa bribe charges</a></h4><ul><li>As reported yesterday, Och-Ziff (NYSE:<a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a>) has settled U.S. charges over the alleged payments of bribes in Africa. <a href=\"http://www.marketwatch.com/story/och-ziff-paying-over-400-million-to-settle-bribery-charges-2016-09-29\" target=\"_blank\">The company will pay</a> $200M to the SEC as well as a criminal penalty of $213 to the DOJ.</li><li>In addition, CEO Dan Och will pay about $2.2M to the SEC to settle charges against him. CFO Joel Frank's will be assessed a penalty at a later date.</li><li>The stock continues to rally as the settlement won't be crimping the company's operations in any way. Shares&nbsp;<font color='green'>+7%</font>&nbsp;today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211608\" data-linked=\"Och-Ziff to pay $413M over Africa bribe charges\" data-tweet=\"$OZM $SCU - Och-Ziff to pay $413M over Africa bribe charges https://seekingalpha.com/news/3211608-och-ziff-to-pay-413m-over-africa-bribe-charges?source=tweet\" data-url=\"https://seekingalpha.com/news/3211608-och-ziff-to-pay-413m-over-africa-bribe-charges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211607\" data-ts=\"1475174986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AET\" target=\"_blank\">AET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211607-aetna-subsidizing-apple-watch-fitbit-gets-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aetna subsidizing Apple Watch: Fitbit gets downgrade</a></h4><ul>   <li>Aetna's (<a href=\"https://seekingalpha.com/symbol/AET\" title=\"Aetna, Inc.\">AET</a> <font color=\"red\">-0.7%</font>) made a hefty move toward Apple's (<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a> <font color=\"red\">-1.5%</font>) wearables platform, and it's having ripple effects on the competition.</li>    <li>Aetna's choice to subsidize Apple Watches for select employers and individual customers during this healthcare enrollment season comes along with a decision to offer the watch for free to its nearly 50,000 workers (not to mention some privacy concerns around insurers having direct access to health measurements).</li>\n<li>The insurer is also pushing a number of iOS exclusive health apps and associated programs for managing health.</li>    <li>That deal's also a <a href=\"http://www.investors.com/news/technology/click/fitbit-downgraded-on-charge-2-reception-apple-watch-win/\" target=\"_blank\">\"substantial negative\" for Fitbit</a> (<a href=\"https://seekingalpha.com/symbol/FIT\" title=\"Fitbit, Inc.\">FIT</a> <font color=\"red\">-9.5%</font>), says Pacific Crest's Brad Erickson, who downgraded that stock to Underweight with a fair value of $11 (shares are trading off heavily at $15.11 today).</li>    <li>Erickson says checks indicate Fitbit's flagship holiday offering, the Charge 2, is off to a slow start: \"Inventory is accumulating in the channel and sell-through is below initial Blaze/Alta levels.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211607\" data-linked=\"Aetna subsidizing Apple Watch: Fitbit gets downgrade\" data-tweet=\"$AET $AET $AAPL - Aetna subsidizing Apple Watch: Fitbit gets downgrade https://seekingalpha.com/news/3211607-aetna-subsidizing-apple-watch-fitbit-gets-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3211607-aetna-subsidizing-apple-watch-fitbit-gets-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>92&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211602\" data-ts=\"1475173532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211602-brazil-oil-workers-reject-latest-petrobras-offer-prepare-for-strike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil oil workers reject latest Petrobras offer, prepare for strike</a></h4><ul>     <li>Brazil's largest oil workers' federation says its members voted overwhelmingly to reject a contract offer from Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"red\">-1.6%</font>) and are <a href=\"http://www.reuters.com/article/us-petrobras-union-strikevote-idUSKCN11Z2EV\" target=\"_blank\">preparing for a possible strike</a>.</li>     <li>PBR says the union's  decision has had no effect on operations, although some workers apparently blocked a heliport used to access the company's offshore oil fields in the Campos basin.</li>     <li>PBR typically has given wage increases well in excess of inflation, but Brazil's inflation hit 8.9% in the 12 months ending Aug 31, and CEO Pedro Parente has said the company's financial situation would not allow such wage increases this time.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211602\" data-linked=\"Brazil oil workers reject latest Petrobras offer, prepare for strike\" data-tweet=\"$PBR - Brazil oil workers reject latest Petrobras offer, prepare for strike https://seekingalpha.com/news/3211602-brazil-oil-workers-reject-latest-petrobras-offer-prepare-for-strike?source=tweet\" data-url=\"https://seekingalpha.com/news/3211602-brazil-oil-workers-reject-latest-petrobras-offer-prepare-for-strike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211600\" data-ts=\"1475172180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211600-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/YZC' title='Yanzhou Coal Mining Co. Ltd.'>YZC</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corp.'>MPC</a> <font color='red'>-8%</font>. TSO <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211600\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$TAT $PACD $SPN - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3211600-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3211600-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211595\" data-ts=\"1475170217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211595-stocks-add-to-losses-on-deutsche-worries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks add to losses on Deutsche worries</a></h4><ul><li>A report that a number of hedge funds <a href=\"https://seekingalpha.com/news/3211591-deutsche-bank-renews-tumble-report-hedge-fund-flush\" target=\"_blank\">are bailing out of </a>their Deutsche Bank exposure has sent that stock sharply lower in the last few minutes, and the move is dragging the big U.S. banks, and in turn, the major averages.</li><li>Deutsche is now lower by&nbsp;<font color='red'>more than 7%</font>. Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-1.2%</font>), Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='red'>-1.6%</font>), JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-1.2%</font>), Goldman Sachs (<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a> <font color='red'>-2.1%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='red'>-1.9%</font>). The <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> and <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> are each&nbsp;<font color='red'>off 1.1%</font>.</li><li>The Dow (<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a> <font color='red'>-0.9%</font>), S&amp;P 500 (<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a> <font color='red'>-0.8%</font>), and Nasdaq (<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a> <font color='red'>-0.6%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3211595\" data-linked=\"Stocks add to losses on Deutsche worries\" data-tweet=\"$BAC $BAC $C - Stocks add to losses on Deutsche worries https://seekingalpha.com/news/3211595-stocks-add-to-losses-on-deutsche-worries?source=tweet\" data-url=\"https://seekingalpha.com/news/3211595-stocks-add-to-losses-on-deutsche-worries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211591\" data-ts=\"1475169863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211591-deutsche-bank-renews-tumble-on-report-of-hedge-fund-flush\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank renews tumble on report of hedge fund flush</a></h4><ul><li>Previously quietly cruising along this session, Deutsche Bank (<a href=\"https://seekingalpha.com/symbol/DB\" title=\"Deutsche Bank AG\">DB</a> <font color=\"red\">-6.6%</font>) has dropped sharply in the last few minutes, <a href=\"http://www.bloomberg.com/news/articles/2016-09-29/some-deutsche-bank-clients-said-to-reduce-collateral-on-trades\" target=\"_blank\">with a report of a number </a>of hedge funds cutting back their exposure to the bank.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211591\" data-linked=\"Deutsche Bank renews tumble on report of hedge fund flush\" data-tweet=\"$DB - Deutsche Bank renews tumble on report of hedge fund flush https://seekingalpha.com/news/3211591-deutsche-bank-renews-tumble-on-report-of-hedge-fund-flush?source=tweet\" data-url=\"https://seekingalpha.com/news/3211591-deutsche-bank-renews-tumble-on-report-of-hedge-fund-flush\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211590\" data-ts=\"1475169613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBH\" target=\"_blank\">SBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211590-sally-beauty-holdings-tracks-lower-after-cfo-departs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sally Beauty Holdings tracks lower after CFO departs</a></h4><ul><li>Sally Beauty Holdings (<a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a> <font color='red'>-6.9%</font>) falls after the company disclosed the resignation of CFO Mark Flaherty</li><li>The company Flaherty didn't step down due to a disagreement with it over operations or policies.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/1368458/000110465916147290/a16-19180_18k.htm\" target=\"_blank\">SEC Form 8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3211590\" data-linked=\"Sally Beauty Holdings tracks lower after CFO departs\" data-tweet=\"$SBH - Sally Beauty Holdings tracks lower after CFO departs https://seekingalpha.com/news/3211590-sally-beauty-holdings-tracks-lower-after-cfo-departs?source=tweet\" data-url=\"https://seekingalpha.com/news/3211590-sally-beauty-holdings-tracks-lower-after-cfo-departs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211589\" data-ts=\"1475169455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211589-dow-jones-qualcomm-in-talks-to-buy-nxp-semi-for-30b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dow Jones: Qualcomm in talks to buy NXP Semi for more than $30B</a></h4><ul><li>A deal <a href=\"http://www.streetinsider.com/Hot+M+and+A/Qualcomm+%28QCOM%29+in+Talks+to+Acquire+NXP+Semiconductors+%28NXPI%29+-+DJ/12084896.html\" target=\"_blank\">could be struck</a> in the next two to three months, according to the report.</li><li><a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>&nbsp;<font color='green'>+11.4%</font>, <a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>&nbsp;<font color='green'>+2%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3211589\" data-linked=\"Dow Jones: Qualcomm in talks to buy NXP Semi for more than $30B\" data-tweet=\"$NXPI $NXPI $QCOM - Dow Jones: Qualcomm in talks to buy NXP Semi for more than $30B https://seekingalpha.com/news/3211589-dow-jones-qualcomm-in-talks-to-buy-nxp-semi-for-30b?source=tweet\" data-url=\"https://seekingalpha.com/news/3211589-dow-jones-qualcomm-in-talks-to-buy-nxp-semi-for-30b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211588\" data-ts=\"1475168984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTD\" target=\"_blank\">AMTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211588-td-ameritrade-jumps-on-scottrade-rumor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TD Ameritrade jumps on Scottrade rumor</a></h4><ul>\n<li>A <a href=\"http://www.bloomberg.com/news/articles/2016-09-28/brokerage-scottrade-said-to-work-with-adviser-on-possible-sale\" target=\"_blank\">Bloomberg story last night</a> said Scottrade is working with an adviser on a sale that would value the company in the $4B range.</li>\n<li>Among those with interest is TD Ameritrade (<a href=\"https://seekingalpha.com/symbol/AMTD\" title=\"TD Ameritrade Holding Corporation\">AMTD</a> <font color=\"green\">+5.2%</font>), according to the story. With the industry struggling with sluggish trading volumes, low interest rates, and lower-cost rivals, a purchase would give Ameritrade the opportunity to profit by eliminating redundant back-office systems while bringing in new customers, says Bloomberg's David Ritter.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211588\" data-linked=\"TD Ameritrade jumps on Scottrade rumor\" data-tweet=\"$AMTD - TD Ameritrade jumps on Scottrade rumor https://seekingalpha.com/news/3211588-td-ameritrade-jumps-on-scottrade-rumor?source=tweet\" data-url=\"https://seekingalpha.com/news/3211588-td-ameritrade-jumps-on-scottrade-rumor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211585\" data-ts=\"1475168556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211585-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NRT' title='North European Oil Royalty Trust'>NRT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CIA' title='Citizens, Inc.'>CIA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/IBN' title='ICICI Bank Ltd.'>IBN</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211585\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$NRT $AMTD $CIA - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3211585-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3211585-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211582\" data-ts=\"1475168212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211582-caterpillar-no-longer-dog-rising-7-in-two-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar no longer a dog, rising 7% in two days</a></h4><ul>     <li>Caterpillar (<a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a> <font color=\"green\">+1.8%</font>) rises to a new 52-week high as it builds on yesterday's breakout momentum following OPEC's agreement to cut production.</li>     <li>CAT has been one of many companies to suffer alongside commodities price, but as oil and gold have rebounded in 2016, so has mining supplier CAT, and the stock has surged more than 7% over the past two days.</li>     <li>In addition to the commodity comeback, Longbow Research's Eli Lustgarten says CAT's 2016 surge is due to \"accelerated restructuring as well as the company downsizing to a new reality.\"</li>     <li>Deutsche Bank recently tabbed CAT as <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/09/07/caterpillar-the-next-deere/\" target=\"_blank\">one of its top picks</a>, believing that natural resource markets have bottomed, and CAT can grow earnings independent of volumes.</li>     <li>Some technical analysts are getting excited too: Now that CAT has broken through the $84 level that Evercore ISI's Rich Ross said served as \"resistance,\" he says the stock presents an <a href=\"http://www.cnbc.com/2016/09/29/why-cat-is-no-longer-a-dog.html\" target=\"_blank\">attractive buying opportunity</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211582\" data-linked=\"Caterpillar no longer a dog, rising 7% in two days\" data-tweet=\"$CAT - Caterpillar no longer a dog, rising 7% in two days https://seekingalpha.com/news/3211582-caterpillar-no-longer-dog-rising-7-in-two-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3211582-caterpillar-no-longer-dog-rising-7-in-two-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211581\" data-ts=\"1475167560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211581-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/CATB\" title=\"Catabasis Pharmaceuticals\">CATB</a> <font color=\"green\">+58%</font>. AEGR <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/MRUS\" title=\"Merus\">MRUS</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/DRNA\" title=\"Dicerna Pharmaceuticals, Inc.\">DRNA</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/AREX\" title=\"Approach Resources Inc.\">AREX</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/EFOI\" title=\"Energy Focus, Inc.\">EFOI</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/MIME\" title=\"Mimecast\">MIME</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/PACD\" title=\"Pacific Drilling SA\">PACD</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/PES\" title=\"Pioneer Energy Services\">PES</a> <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ITCI\" title=\"Intra-Cellular Therapies Inc.\">ITCI</a> <font color=\"red\">-63%</font>. ADHD <font color=\"red\">-55%</font>. <a href=\"https://seekingalpha.com/symbol/MRNS\" title=\"Marinus Pharmaceuticals\">MRNS</a> <font color=\"red\">-27%</font>. <a href=\"https://seekingalpha.com/symbol/ATNM\" title=\"Actinium Pharmaceuticals, Inc.\">ATNM</a> <font color=\"red\">-22%</font>. <a href=\"https://seekingalpha.com/symbol/RGSE\" title=\"RGS Energy, Inc.\">RGSE</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CCIH\" title=\"ChinaCache International\">CCIH</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/SMRT\" title=\"Stein Mart, Inc.\">SMRT</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/ASMB\" title=\"Assembly Biosciences, Inc.\">ASMB</a> <font color=\"red\">-10%</font>. SONS <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211581\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CATB $NVLNF $BSPM - Midday Gainers / Losers https://seekingalpha.com/news/3211581-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3211581-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211580\" data-ts=\"1475166145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211580-goldman-sticks-to-bearish-oil-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman sticks to bearish oil outlook</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/news/3210957-goldman-slashes-oil-price-outlook\" target=\"_blank\">Goldman's cutting of</a> its outlook for the price of oil earlier this week is looking particularly ill-timed as one day later <a href=\"https://seekingalpha.com/news/3211377-opec-reportedly-agrees-first-production-cut-8-years\" target=\"_blank\">OPEC looked to have</a> reach some sort of deal to cut production, sending crude <font color=\"green\">5% higher </font>yesterday and <font color=\"green\">upward another 2% </font>today (to $48 per barrel).</li>\n<li>Goldman, however, is sticking to its guns. Acknowledging a \"strictly implemented\" deal could add $7-$10 per barrel to the price of crude, analyst Damien Courvalin and team remind OPEC's member countries tend to cheat on their quotas.</li>\n<li>They also note Iran and Libya are not part of the new agreement, and production for those outside of OPEC would surely rise alongside any increase in price.</li>\n<li>They reiterate their $43 year-end target and $53 for the end of 2017.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a> <font color=\"green\">+2.9%</font>\n</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>, <a href=\"https://seekingalpha.com/symbol/OILX\" title=\"Etracs S&amp;P GSCI Crude Oil Total Return Index ETN\">OILX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211580\" data-linked=\"Goldman sticks to bearish oil outlook\" data-tweet=\"$USO $OIL $UWTI - Goldman sticks to bearish oil outlook https://seekingalpha.com/news/3211580-goldman-sticks-to-bearish-oil-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3211580-goldman-sticks-to-bearish-oil-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211578\" data-ts=\"1475165378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAS\" target=\"_blank\">BAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211578-basic-energyplus-33-forbearance-agreement-extended\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Basic Energy +33% as forbearance agreement extended</a></h4><ul>     <li>Basic Energy Services (<a href=\"https://seekingalpha.com/symbol/BAS\" title=\"Basic Energy Services, Inc.\">BAS</a> <font color=\"green\">+33.7%</font>) surges nearly 35% following extensions of its forbearance agreement with lenders and waivers to continue deleveraging negotiations.</li>     <li>BAS says it has continued to make progress in negotiations with creditors regarding a deleveraging transaction, and has reached an agreement with 81% of the holders of its 2019 notes to extend the forbearance period through  Oct. 16.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211578\" data-linked=\"Basic Energy +33% as forbearance agreement extended\" data-tweet=\"$BAS - Basic Energy +33% as forbearance agreement extended https://seekingalpha.com/news/3211578-basic-energyplus-33-forbearance-agreement-extended?source=tweet\" data-url=\"https://seekingalpha.com/news/3211578-basic-energyplus-33-forbearance-agreement-extended\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211576\" data-ts=\"1475164655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211576-anadarkoplus-2_5-freeport-disregards-lender-dissent-in-2b-asset-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadarko +2.5% as Freeport disregards lender dissent in $2B asset sale</a></h4><ul>     <li>Anadarko Petroleum (<a href=\"https://seekingalpha.com/symbol/APC\" title=\"Anadarko Petroleum Corporation\">APC</a> <font color=\"green\">+2.5%</font>) is higher as Freeport McMoRan (<a href=\"https://seekingalpha.com/symbol/FCX\" title=\"Freeport-McMoRan Inc.\">FCX</a> <font color=\"red\">-0.4%</font>) <a href=\"http://www.bloomberg.com/news/articles/2016-09-29/freeport-disregards-lender-dissent-in-2-billion-anadarko-sale\" target=\"_blank\">pushes ahead with plans for a $2B asset sale</a> to the company even after <a href=\"https://seekingalpha.com/news/3211147-bloomberg-freeport-s-2b-asset-sale-anadarko-hit-lender-dissent\" target=\"_blank\">failing to win creditor support</a> for the deal.</li>     <li>FCX says it will merge with a subsidiary to get around the obstacle thrown up by its bondholders, even as creditors say the move violates their agreement with the company.</li>     <li>FCX initially sought consent from creditors to change the existing agreement but says the offer expired yesterday evening after creditors had failed to give their approval.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211576\" data-linked=\"Anadarko +2.5% as Freeport disregards lender dissent in $2B asset sale\" data-tweet=\"$APC $APC $FCX - Anadarko +2.5% as Freeport disregards lender dissent in $2B asset sale https://seekingalpha.com/news/3211576-anadarkoplus-2_5-freeport-disregards-lender-dissent-in-2b-asset-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3211576-anadarkoplus-2_5-freeport-disregards-lender-dissent-in-2b-asset-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211577\" data-ts=\"1475164120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIK\" target=\"_blank\">TIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211577-tel-instrument-electronicsplus-5-after-winning-contract-from-u-s-army\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tel Instrument Electronics +5% after winning contract from the U.S. Army</a></h4><ul>     <li>Tel Instrument Electronics (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/TIK\" title=\"Tel-Instrument Electronics Corp\">TIK</a>) announced that it has received a 4 year Indefinite Delivery Indefinite Quantity (\"IDIQ\") contract with a maximum contract value of $1.15M.</li>     <li>As part of this IDIQ contract, the Company has received an initial delivery order from the U.S. Army for 15 T-47NH Test Sets for a total consideration of $0.28M. The company expects that the units on this initial delivery order will be shipped this fiscal year ending March 31, 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211577\" data-linked=\"Tel Instrument Electronics +5% after winning contract from the U.S. Army\" data-tweet=\"$TIK - Tel Instrument Electronics +5% after winning contract from the U.S. Army https://seekingalpha.com/news/3211577-tel-instrument-electronicsplus-5-after-winning-contract-from-u-s-army?source=tweet\" data-url=\"https://seekingalpha.com/news/3211577-tel-instrument-electronicsplus-5-after-winning-contract-from-u-s-army\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211541\" data-ts=\"1475161244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211541-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+49%</font>. <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+21%</font>. AEGR <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='green'>+8%</font>. QLTI <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color='red'>-63%</font>. ADHD <font color='red'>-55%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211541\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CATB $BSPM $NVLNF - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3211541-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3211541-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211561\" data-ts=\"1475160473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCAF\" target=\"_blank\">SNCAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211561-snc-lavalin-cuts-2016-profit-guidance-citing-middle-east-oil-and-gas-projects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SNC-Lavalin cuts 2016 profit guidance, citing Middle East oil and gas projects</a></h4><ul>     <li>SNC-Lavalin (<a href=\"https://seekingalpha.com/symbol/SNCAF\" title=\"SNC Lavalin Group Inc.A\">OTCPK:SNCAF</a>) sinks as much as 6% in Toronto trading after <a href=\"http://www.bloomberg.com/news/articles/2016-09-29/snc-lavalin-drops-most-in-more-than-a-year-as-profit-target-cut\" target=\"_blank\">cutting its FY 2016 adjusted profit forecast</a> for its engineering and construction business because of cost overruns on two oil and gas projects in the Middle East.</li>     <li>The company says it expects full-year adjusted EPS for the core  business at C$1.30-C$1.60, lower than its previous  forecast of C$1.50-C$1.70, and Q3 results will include unspecified \"unfavorable cost and revenue re-forecasts\u201d on the two projects.</li>     <li>The engineering and construction business contributed two-thirds of SNC\u2019s adjusted Q2 profit.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211561\" data-linked=\"SNC-Lavalin cuts 2016 profit guidance, citing Middle East oil and gas projects\" data-tweet=\"$SNCAF - SNC-Lavalin cuts 2016 profit guidance, citing Middle East oil and gas projects https://seekingalpha.com/news/3211561-snc-lavalin-cuts-2016-profit-guidance-citing-middle-east-oil-and-gas-projects?source=tweet\" data-url=\"https://seekingalpha.com/news/3211561-snc-lavalin-cuts-2016-profit-guidance-citing-middle-east-oil-and-gas-projects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211555\" data-ts=\"1475159599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211555-apple-down-1-barclays-pulls-top-pick-claim-of-exploding-iphone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple down 1%: Barclays pulls as a Top Pick, claim of exploding iPhone</a></h4><ul><li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) is&nbsp;<font color='red'>down 1%</font>&nbsp;in morning action, with <a href=\"http://www.streetinsider.com/Analyst+Comments/Apple+%28AAPL%29+No+Longer+Seen+as+Top+Pick+at+Barclays/12082895.html\" target=\"_blank\">Barclays pulling</a> the stock as a Top Pick, though still rating it at Outperform.</li><li>There's also a <a href=\"https://www.reddit.com/r/apple/comments/54te00/running_a_little_hot/\" target=\"_blank\">post on a Reddit thread </a>in which someone claims to have received their new iPhone 7 <a href=\"http://cdn.bgr.com/2016/09/lyppqjz.jpg?quality=98&amp;strip=all&amp;strip=all\" target=\"_blank\">in this condition</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211555\" data-linked=\"Apple down 1%: Barclays pulls as a Top Pick, claim of exploding iPhone\" data-tweet=\"$AAPL - Apple down 1%: Barclays pulls as a Top Pick, claim of exploding iPhone https://seekingalpha.com/news/3211555-apple-down-1-barclays-pulls-top-pick-claim-of-exploding-iphone?source=tweet\" data-url=\"https://seekingalpha.com/news/3211555-apple-down-1-barclays-pulls-top-pick-claim-of-exploding-iphone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>160&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211554\" data-ts=\"1475159562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211554-dicks-sporting-goods-lower-after-negative-call-from-off-wall-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dick&#39;s Sporting Goods lower after negative call from Off Wall Street</a></h4><ul> <li>Dick's Sporting Goods (<a href=\"https://seekingalpha.com/symbol/DKS\" title=\"Dick's Sporting Goods, Inc.\">DKS</a> <font color=\"red\">-2.8%</font>) is under pressure after <a href=\"http://www.offwallstreet.com/ideas/\" target=\"_blank\">Off Wall Street</a> fires off a Strong Sell rating on the retailer.</li> <li>Channel checks from the firm show a lower level of store traffic and there are margin concerns due to a higher mix of small Dick's stores.</li> <li>Off Wall Street's price target of $39 implies a significant downward swing for the sporting good retailer.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3211554\" data-linked=\"Dick&#39;s Sporting Goods lower after negative call from Off Wall Street\" data-tweet=\"$DKS - Dick&#39;s Sporting Goods lower after negative call from Off Wall Street https://seekingalpha.com/news/3211554-dicks-sporting-goods-lower-after-negative-call-from-off-wall-street?source=tweet\" data-url=\"https://seekingalpha.com/news/3211554-dicks-sporting-goods-lower-after-negative-call-from-off-wall-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211553\" data-ts=\"1475159474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211553-natural-gas-futures-turn-green-on-inventory-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas futures turn green on inventory data</a></h4><ul>\n<li>\n<a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+49</strong><strong> Bcf</strong> vs. +55 Bcf consensus, +52 Bcf last week.</li>\n<li>Futures <font color=\"green\">+0.1%</font> to $3.006.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/UNG\" title=\"The United States Natural Gas ETF, LP\">UNG</a>, <a href=\"https://seekingalpha.com/symbol/DGAZ\" title=\"VelocityShares 3x Inverse Natural Gas ETN\">DGAZ</a>, <a href=\"https://seekingalpha.com/symbol/UGAZ\" title=\"VelocityShares 3x Long Natural Gas ETN\">UGAZ</a>, <a href=\"https://seekingalpha.com/symbol/BOIL\" title=\"ProShares Ultra Bloomberg Natural Gas ETF\">BOIL</a>, <a href=\"https://seekingalpha.com/symbol/GAZ\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ</a>, <a href=\"https://seekingalpha.com/symbol/KOLD\" title=\"ProShares UltraShort Bloomberg Natural Gas ETF\">KOLD</a>, <a href=\"https://seekingalpha.com/symbol/UNL\" title=\"The United States 12 Month Natural Gas ETF, LP\">UNL</a>, <a href=\"https://seekingalpha.com/symbol/DCNG\" title=\"iPath Pure Beta Seasonal Natural Gas ETN\">DCNG</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211553\" data-linked=\"Natural gas futures turn green on inventory data\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas futures turn green on inventory data https://seekingalpha.com/news/3211553-natural-gas-futures-turn-green-on-inventory-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3211553-natural-gas-futures-turn-green-on-inventory-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211550\" data-ts=\"1475158596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCT\" target=\"_blank\">ARCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211550-fda-places-alcobras-mdx-program-on-clinical-hold-due-to-adverse-effects-shares-down-57\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA places Alcobra&#39;s MDX program on clinical hold due to adverse effects; shares down 57%</a></h4><ul>\n<li>Thinly traded nano cap Alcobra (ADHD <font color=\"red\">-56.8%</font>) plummets on a 23x surge in volume in response to its announcement that it has received verbal notice from the FDA that its Metadoxine Extended Release (MDX) program has been placed on full clinical hold due to adverse neurological findings in a preclinical study. The action suspends recruitment and dosing in its Phase 3 MEASURE study in adults with attention deficit hyperactivity disorder despite the absence of questionable safety data. There have also been no safety issues in previous MDX clinical trials.</li>\n<li>The company intends to work closely with the agency to remove the clinical hold.</li>\n<li>MDX is a modulator of <a href=\"http://www.denvernaturopathic.com/news/GABA.html\" target=\"_blank\">GABA </a>(gamma-aminobutyric acid), an abundant neurotransmitter in the central nervous system, especially in the cerebral cortex where thinking occurs and sensations are interpreted. It is also being developed for Fragile X syndrome.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211550\" data-linked=\"FDA places Alcobra&#39;s MDX program on clinical hold due to adverse effects; shares down 57%\" data-tweet=\"$ARCT - FDA places Alcobra&#39;s MDX program on clinical hold due to adverse effects; shares down 57% https://seekingalpha.com/news/3211550-fda-places-alcobras-mdx-program-on-clinical-hold-due-to-adverse-effects-shares-down-57?source=tweet\" data-url=\"https://seekingalpha.com/news/3211550-fda-places-alcobras-mdx-program-on-clinical-hold-due-to-adverse-effects-shares-down-57\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211546\" data-ts=\"1475158224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKY\" target=\"_blank\">PKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211546-cousins-properties-downgraded-ahead-of-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cousins Properties downgraded ahead of merger</a></h4><ul>\n<li>The merger with Parkway Properties (NYSE:<a href=\"https://seekingalpha.com/symbol/PKY\" title=\"Parkway Properties Inc.\">PKY</a>) is set to close on Oct. 6, with the spinoff of the Houston-based assets of the two companies to take place alongside.</li>\n<li>Stifel today downgrades Cousins (NYSE:<a href=\"https://seekingalpha.com/symbol/CUZ\" title=\"Cousins Properties Inc.\">CUZ</a>) to Sell, with PT cut to $9.50 from $11.50.</li>\n<li>CUZ is <font color=\"red\">lower by 3.05%</font> to $10.46, and PKY <font color=\"red\">by 2.45%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211546\" data-linked=\"Cousins Properties downgraded ahead of merger\" data-tweet=\"$PKY $PKY $CUZ - Cousins Properties downgraded ahead of merger https://seekingalpha.com/news/3211546-cousins-properties-downgraded-ahead-of-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3211546-cousins-properties-downgraded-ahead-of-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211540\" data-ts=\"1475157492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OZM\" target=\"_blank\">OZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211540-och-ziff-capital-upgraded-following-africa-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Och-Ziff Capital upgraded following Africa settlement</a></h4><ul>\n<li>The stock had a big day yesterday <a href=\"https://seekingalpha.com/news/3211351-bloomberg-och-ziff-plead-guilty-african-bribes\" target=\"_blank\">after Bloomberg</a> reported Och-Ziff (NYSE:<a href=\"https://seekingalpha.com/symbol/OZM\" title=\"Och-Ziff Capital Management Group LLC\">OZM</a>) as being close to settling African bribery charges. The deferred prosecution agreement allows the company to operate as normal, with charges eventually being dropped if OZM stays out of trouble for a period.</li>\n<li>Compass Point <a href=\"http://www.streetinsider.com/Upgrades/Compass+Point+Upgrades+Och-Ziff+Capital+Management+Group+%28OZM%29+to+Buy/12083824.html\" target=\"_blank\">upgrades to Buy </a>from Neutral. The $5 PT suggests another <font color=\"green\">17-18% upside</font> from yesterday's close.</li>\n<li>Shares <font color=\"green\">+1.2%</font> today to $4.30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211540\" data-linked=\"Och-Ziff Capital upgraded following Africa settlement\" data-tweet=\"$OZM $SCU - Och-Ziff Capital upgraded following Africa settlement https://seekingalpha.com/news/3211540-och-ziff-capital-upgraded-following-africa-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3211540-och-ziff-capital-upgraded-following-africa-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211536\" data-ts=\"1475156935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMBL\" target=\"_blank\">NMBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211536-nimble-storage-boosted-wells-fargo-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nimble Storage boosted by Wells Fargo upgrade</a></h4><ul>\n<li>Analyst Maynard Um <a href=\"http://www.streetinsider.com/Analyst+Comments/Wells+Fargo+Upgrades+Nimble+Storage+%28NMBL%29+to+Outperform/12082859.html\" target=\"_blank\">expects growth to be driven</a> by: \"1) a strong pipeline for its all-flash array in a secularly growing market and 2) our expectations for better performance in its hybrid arrays than the implied decline in our/Street\u2019s F18 forecast.\"</li>\n<li>Further ... \"We believe the risk/reward is additionally skewed positively given our view that 1) there is limited near-term risk as we think management may have taken a more conservative approach to guidance given issues last year, 2) gross margins will remain relatively stable, 3) its InfoSight predictive analytic engine offers differentiation, and 4) organizational changes made earlier this year and channel roadshows in Sept should start yielding benefits in the next couple of quarters.\"</li>\n<li>He upgrades to Outperform with PT range of $10-$11, up $1 at both ends from previous.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/NMBL\" title=\"Nimble Storage, Inc.\">NMBL</a> <font color=\"green\">+4.25%</font> to $8.48.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211536\" data-linked=\"Nimble Storage boosted by Wells Fargo upgrade\" data-tweet=\"$NMBL - Nimble Storage boosted by Wells Fargo upgrade https://seekingalpha.com/news/3211536-nimble-storage-boosted-wells-fargo-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3211536-nimble-storage-boosted-wells-fargo-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211534\" data-ts=\"1475156684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSET\" target=\"_blank\">BSET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211534-on-bassett-furnitures-fq3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Bassett Furniture&#39;s FQ3</a></h4><ul>     <li>Bassett Furniture (<a href=\"https://seekingalpha.com/symbol/BSET\" title=\"Bassett Furniture Industries, Incorporated\">BSET</a> <font color=\"red\">-4.2%</font>) reports comparable-store sales fell 0.9% in FQ3.</li>     <li>Wholesale segment revenue decreased 6.2% to $58.3M.</li>     <li>Retail segment revenue slipped 1.3% to $61.2M.</li>     <li>Logistical services revenue dropped 2.8% to $22.99M.</li>     <li>The gross margin rate improved 210 bps to 61.7%.</li>     <li>Operating margin rate grew 30 bps to 7.2%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211534\" data-linked=\"More on Bassett Furniture&#39;s FQ3\" data-tweet=\"$BSET - More on Bassett Furniture&#39;s FQ3 https://seekingalpha.com/news/3211534-on-bassett-furnitures-fq3?source=tweet\" data-url=\"https://seekingalpha.com/news/3211534-on-bassett-furnitures-fq3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211530\" data-ts=\"1475155787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211530-relief-rally-for-pier-1-imports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Relief rally for Pier 1 Imports</a></h4><ul> <li>Shares of Pier 1 Imports (NYSE:<a href=\"https://seekingalpha.com/symbol/PIR\" title=\"Pier 1 Imports Inc.\">PIR</a>) are racing higher in early action after the company showed a narrower loss than anticipated with its FQ2 report.</li> <li>The company sees FQ3 EPS of $0.09-$0.15 vs $0.12 consensus and FQ4 EPS of $0.24-$0.32. Comparable sales are seen falling in -3% to -1% range for both of the upcoming quarters.</li> <li>PIR <font color=\"green\">+5.62%</font> premarket to $4.51. Trading on Pier 1 could be volatile with a poison pill and activist investors in the background.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3211398-pier-1-imports-declares-0_07-dividend\" target=\"_blank\">Pier 1 Imports declares $0.07 dividend</a> (Sept. 28)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3211389-pier-1-imports-eps-line-misses-revenue\" target=\"_blank\">Pier 1 Imports EPS in-line, misses on revenue</a> (Sept. 28)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3211401-pier-1-imports-navigates-traffic-pressure\" target=\"_blank\">Pier 1 Imports navigates through traffic pressure</a> (Sept. 28)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3211530\" data-linked=\"Relief rally for Pier 1 Imports\" data-tweet=\"$PIR - Relief rally for Pier 1 Imports https://seekingalpha.com/news/3211530-relief-rally-for-pier-1-imports?source=tweet\" data-url=\"https://seekingalpha.com/news/3211530-relief-rally-for-pier-1-imports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211527\" data-ts=\"1475155389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211527-marinus-pharmas-ganaxolone-shows-seizure-reducing-effect-in-11-subject-epilepsy-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marinus Pharma&#39;s ganaxolone shows seizure-reducing effect in 11-subject epilepsy study; investors unimpressed, shares down 5% premarket</a></h4><ul>\n<li>Nano cap Marinus Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MRNS\" title=\"Marinus Pharmaceuticals\">MRNS</a>) eases<font color=\"red\"> 5%</font> premarket on robust volume in response to its announcement of top-line results from a small exploratory open-label study of GABA modulator ganaxolone in females with PCDH19 pediatric epilepsy, an Orphan Drug designation by the FDA.</li>\n<li>64% (n=7/11) of patients experienced a reduction in seizures from baseline with 54% of the responders (n=4/7) showing a reduction greater than 50%.</li>\n<li>73% (n=8/11) experienced an increase in seizure-free days.</li>\n<li>The trial evaluated ganaxolone as adjunctive treatment, administered as oral liquid suspension or capsules, for 26 weeks after establishing baseline seizure frequency up to 12 weeks.</li>\n<li>\n<a href=\"http://www.marinuspharma.com/#!ganaxolone/cxnj\" target=\"_blank\">Ganaxolone </a>is a small molecule inhibitor of the neurotransmitter GABA, which helps control epileptic seizures.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211527\" data-linked=\"Marinus Pharma&#39;s ganaxolone shows seizure-reducing effect in 11-subject epilepsy study; investors unimpressed, shares down 5% premarket\" data-tweet=\"$MRNS - Marinus Pharma&#39;s ganaxolone shows seizure-reducing effect in 11-subject epilepsy study; investors unimpressed, shares down 5% premarket https://seekingalpha.com/news/3211527-marinus-pharmas-ganaxolone-shows-seizure-reducing-effect-in-11-subject-epilepsy-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3211527-marinus-pharmas-ganaxolone-shows-seizure-reducing-effect-in-11-subject-epilepsy-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211525\" data-ts=\"1475154921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211525-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> AEGR <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color='red'>-66%</font>. ADHD <font color='red'>-59%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-22%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3211525\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$NVLNF $CATB $ARWR - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3211525-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3211525-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211524\" data-ts=\"1475154775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211524-chesapeake-energyminus-4-on-news-of-convertible-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy -4% on news of convertible debt offering</a></h4><ul>     <li>Chesapeake Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/CHK\" title=\"Chesapeake Energy Corporation\">CHK</a>) <font color=\"red\">-4%</font> premarket after announcing a private placement of $850M of convertible debt, with an option for placement of an additional $150M.</li>\n<li>CHK says it plans to use the proceeds for general corporate purposes, including paying down debt and the repayment of credit facilities.</li>\n<li>CHK also confirms it <a href=\"https://www.sec.gov/Archives/edgar/data/895126/000089512616000561/a8-k2016x09x29reconvertibl.htm\" target=\"_blank\">received subpoenas</a> from the U.S. Department of Justice, U.S. Postal Service and  certain state authorities seeking information on royalty payment practices.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211524\" data-linked=\"Chesapeake Energy -4% on news of convertible debt offering\" data-tweet=\"$CHK - Chesapeake Energy -4% on news of convertible debt offering https://seekingalpha.com/news/3211524-chesapeake-energyminus-4-on-news-of-convertible-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3211524-chesapeake-energyminus-4-on-news-of-convertible-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211522\" data-ts=\"1475154229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNM\" target=\"_blank\">ATNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211522-actinium-pharma-launches-equity-offering-shares-down-22-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Actinium Pharma launches equity offering; shares down 22% premarket</a></h4><ul>\n<li>Thinly traded nano cap Actinium Pharmaceuticals (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/ATNM\" title=\"Actinium Pharmaceuticals, Inc.\">ATNM</a>) slumps <font color=\"red\">22% </font>premarket on robust volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1388320/000121390016017124/f8k092816_actiniumpharma.htm\" target=\"_blank\">announcement </a>of a public offering of 8M shares of common stock at $1.25. Underwriters over-allotment is an additional 1.2M shares. Net proceeds should be ~$9.3M. Closing date is October 4.</li>\n<li>Yesterday's close was $1.70.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211522\" data-linked=\"Actinium Pharma launches equity offering; shares down 22% premarket\" data-tweet=\"$ATNM - Actinium Pharma launches equity offering; shares down 22% premarket https://seekingalpha.com/news/3211522-actinium-pharma-launches-equity-offering-shares-down-22-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3211522-actinium-pharma-launches-equity-offering-shares-down-22-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211519\" data-ts=\"1475153829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CATB\" target=\"_blank\">CATB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211519-sarepta-and-catabasis-pharma-team-up-to-explore-combo-drug-for-duchenne-muscular-dystrophy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta and Catabasis Pharma team up to explore a combo drug for Duchenne muscular dystrophy; Catabasis ahead 29% premarket</a></h4><ul>\n<li>Thinly traded nano cap Catabasis Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CATB\" title=\"Catabasis Pharmaceuticals\">CATB</a>) is up <font color=\"green\">29% </font>premarket on increased volume in response to its announcement of a joint research collaboration with Sarepta Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) to investigate a combination drug approach for the treatment of Duchenne muscular dystrophy (DMD). Sarepta will contribute its expertise in exon skipping and Catabasis its know-how in oral NF-kB inhibition, specifically <a href=\"http://www.catabasis.com/technology-pipeline/our-pipeline.php\" target=\"_blank\">edasalonexent </a>(CAT-1004).</li>\n<li>NF-kB, a protein activated in DMD, plays a key role in inflammation and fibrosis.</li>\n<li>Financial terms are not disclosed.</li>\n<li>Sarepta is up <font color=\"green\">1%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211519\" data-linked=\"Sarepta and Catabasis Pharma team up to explore a combo drug for Duchenne muscular dystrophy; Catabasis ahead 29% premarket\" data-tweet=\"$CATB $CATB $SRPT - Sarepta and Catabasis Pharma team up to explore a combo drug for Duchenne muscular dystrophy; Catabasis ahead 29% premarket https://seekingalpha.com/news/3211519-sarepta-and-catabasis-pharma-team-up-to-explore-combo-drug-for-duchenne-muscular-dystrophy?source=tweet\" data-url=\"https://seekingalpha.com/news/3211519-sarepta-and-catabasis-pharma-team-up-to-explore-combo-drug-for-duchenne-muscular-dystrophy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211499\" data-ts=\"1475151066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211499-arrowhead-pharma-inks-two-agreements-amgen-for-rnai-candidates-in-cardiovascular-disease\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead Pharma inks two agreements with Amgen for RNAi candidates in cardiovascular disease; shares up 21% premarket</a></h4><ul>\n<li>Arrowhead Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARWR\" title=\"Arrowhead Pharmaceuticals\">ARWR</a>) is ahead <font color=\"green\">21%</font> premarket on average volume in response to is <a href=\"http://investors.amgen.com/phoenix.zhtml?c=61656&amp;p=RssLanding&amp;cat=news&amp;id=2206771\" target=\"_blank\">announcement</a> of two collaboration deals with Amgen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a>) for RNA interference (RNAi) therapies for cardiovascular disease (CVD) based on its proprietary subcutaneous <a href=\"http://arrowheadpharma.com/science/\" target=\"_blank\">RNAi delivery platform</a>.</li>\n<li>Under the first agreement, Amgen receives a global exclusive license to Arrowhead's RNAi ARC-LPA program, designed to reduce elevated lipoprotein(a), a risk factor for atherosclerotic CVD. The second agreement provides Amgen an option to a global exclusive license for an RNAi therapy for an undisclosed CVD target. Amgen is responsible for clinical development and commercialization under both contracts. Financial terms are not disclosed. The ARC-LPA transaction should close in Q4.</li>\n<li>Arrowhead will host a conference call this morning at 9:00 am ET to discuss the collaborations.</li>\n<li>\n<strong>Update</strong>: On November 21, Arrowhead <a href=\"http://www.businesswire.com/news/home/20161121005878/en/Arrowhead-Pharmaceuticals-Announces-Closing-License-Collaboration-Agreement\" target=\"_blank\">announced </a>the closing of the ARC-LPA agreement.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211499\" data-linked=\"Arrowhead Pharma inks two agreements with Amgen for RNAi candidates in cardiovascular disease; shares up 21% premarket\" data-tweet=\"$ARWR $ARWR $AMGN - Arrowhead Pharma inks two agreements with Amgen for RNAi candidates in cardiovascular disease; shares up 21% premarket https://seekingalpha.com/news/3211499-arrowhead-pharma-inks-two-agreements-amgen-for-rnai-candidates-in-cardiovascular-disease?source=tweet\" data-url=\"https://seekingalpha.com/news/3211499-arrowhead-pharma-inks-two-agreements-amgen-for-rnai-candidates-in-cardiovascular-disease\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211484\" data-ts=\"1475150289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNCA\" target=\"_blank\">GNCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211484-genocea-bios-lead-product-candidate-successful-in-phase-2b-study-in-genital-herpes-phase-3-to\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genocea Bio&#39;s lead product candidate successful in Phase 2b study in genital herpes; Phase 3 to commence in H2 2017; shares up 19% premarket</a></h4><ul>\n<li>Genocea Biosciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GNCA\" title=\"Genocea Biosciences, Inc.\">GNCA</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1457612/000145761216000077/gnca-20160929x991sheddingp.htm\" target=\"_blank\">announces</a> positive top-line results from an ongoing Phase 2b study assessing lead product candidate GEN-003 for the treatment of genital herpes. The trial <a href=\"https://www.sec.gov/Archives/edgar/data/1457612/000145761216000077/gen003003pd3final.htm\" target=\"_blank\">met its primary endpoint</a> demonstrating a statistically valid reduction of 40% from baseline (60 ug per protein/50 ug of Matrix-M2 dose) in the rate of viral shedding compared to placebo (p=0.05). The results were consistent with a prior Phase 2 study.</li>\n<li>The reduction in viral shedding for the 60 ug per protein/75 ug of Matrix-M2 was 27%, superior to placebo but shy of statistical significance.</li>\n<li>A Phase 3 trial evaluating a dose of 60 ug per protein/50 ug of Matrix-M2 is on tap for H2 2017.</li>\n<li>The company will host a conference call this morning at 9:00 am ET to discuss the data.</li>\n<li>Shares are up <font color=\"green\">19%</font> premarket on increased volume.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170673-genocea-bios-genital-herpes-candidate-genminus-003-shows-strong-effect-mid-stage-study-shares\" target=\"_blank\">Genocea Bio's genital herpes candidate GEN-003 shows strong effect in mid-stage study; shares up 38% premarket</a> (March 31)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211484\" data-linked=\"Genocea Bio&#39;s lead product candidate successful in Phase 2b study in genital herpes; Phase 3 to commence in H2 2017; shares up 19% premarket\" data-tweet=\"$GNCA - Genocea Bio&#39;s lead product candidate successful in Phase 2b study in genital herpes; Phase 3 to commence in H2 2017; shares up 19% premarket https://seekingalpha.com/news/3211484-genocea-bios-lead-product-candidate-successful-in-phase-2b-study-in-genital-herpes-phase-3-to?source=tweet\" data-url=\"https://seekingalpha.com/news/3211484-genocea-bios-lead-product-candidate-successful-in-phase-2b-study-in-genital-herpes-phase-3-to\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211486\" data-ts=\"1475150006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAG\" target=\"_blank\">CAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211486-on-conagra-foods-fq1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on ConAgra Foods&#39; FQ1</a></h4><ul>     <li>ConAgra Foods (NYSE:<a href=\"https://seekingalpha.com/symbol/CAG\" title=\"ConAgra Brands, Inc.\">CAG</a>) reports net sales fell 5% in FQ1 due to Company\u2019s decisive actions to build a higher quality revenue base; divestitures and foreign exchange reduced sales by 2%.</li>     <li>Segment net sales: Grocery &amp; Snacks: $757.2M (-5.4%); Refrigerated &amp; Frozen: $604.6M (-8.1%); International: 194.7M (-5.7%); Foodservice: $268M (-1%); Commercial: $843M (-2%).</li>     <li>Gross margin rate expanded 200 bps to 27.3%.</li>     <li>SG&amp;A expense rate improved 390 bps to 10.6%.</li>     <li>Adjusted segment operating margin rate rose 390 bps to 17.6%.</li>          <li>CAG <font color=\"green\">+2.02%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211486\" data-linked=\"More on ConAgra Foods&#39; FQ1\" data-tweet=\"$CAG - More on ConAgra Foods&#39; FQ1 https://seekingalpha.com/news/3211486-on-conagra-foods-fq1?source=tweet\" data-url=\"https://seekingalpha.com/news/3211486-on-conagra-foods-fq1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211482\" data-ts=\"1475149186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211482-fitbit-downgraded-on-slow-start-for-charge-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FitBit downgraded on slow start for Charge 2</a></h4><ul>\n<li>Charge 2 is FitBit's (NYSE:<a href=\"https://seekingalpha.com/symbol/FIT\" title=\"Fitbit, Inc.\">FIT</a>) flagship holiday product, and checks show inventory is accumulating and sell-through is below initial Blaze/Alta levels, says analyst Brad Erickson, <a href=\"http://www.streetinsider.com/Analyst+Comments/Pacific+Crest+Cuts+Fitbit+%28FIT%29+to+Underperform%3B+Charge+2+Off+to+Slow+Start%2C+Says+Analyst/12082623.html\" target=\"_blank\">downgrading to Underperform</a> with $11 price target (yesterday's close was $16.70).</li>\n<li>Shares <font color=\"red\">-4.9%</font> premarket to $15.88.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211482\" data-linked=\"FitBit downgraded on slow start for Charge 2\" data-tweet=\"$FIT - FitBit downgraded on slow start for Charge 2 https://seekingalpha.com/news/3211482-fitbit-downgraded-on-slow-start-for-charge-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3211482-fitbit-downgraded-on-slow-start-for-charge-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211481\" data-ts=\"1475148882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211481-deutsche-ebay-might-be-best-story-in-internet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche: eBay might be best story in Internet</a></h4><ul>\n<li>There aren't a lot of out-of-favor, growth accelerating growth stories with upside to estimates and a reasonably low valuation out there, but <a href=\"https://seekingalpha.com/symbol/EBAY\" title=\"eBay Inc.\">EBAY</a> qualifies, says Deutsche's Ross Sandler, <a href=\"http://thefly.com/landingPageNews.php?id=2437255&amp;headline=EBAY-Deutsche-upgrades-eBay-to-Buy-with--price-target\" target=\"_blank\">upgrading to Buy</a>.</li>\n<li>He lifts the price target to $40 from $30, suggesting 25% upside.</li>\n<li>Shares<font color=\"green\"> +2.4%</font> premarket to $32.61.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211481\" data-linked=\"Deutsche: eBay might be best story in Internet\" data-tweet=\"$EBAY - Deutsche: eBay might be best story in Internet https://seekingalpha.com/news/3211481-deutsche-ebay-might-be-best-story-in-internet?source=tweet\" data-url=\"https://seekingalpha.com/news/3211481-deutsche-ebay-might-be-best-story-in-internet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211478\" data-ts=\"1475148570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNCA\" target=\"_blank\">GNCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211478-trading-in-genocea-bio-and-arrowhead-pharma-suspended-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Genocea Bio and Arrowhead Pharma suspended pending news</a></h4><ul>\n<li>Nasdaq halts trading in Genocea Biosciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GNCA\" title=\"Genocea Biosciences, Inc.\">GNCA</a>) and Arrowhead Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARWR\" title=\"Arrowhead Pharmaceuticals\">ARWR</a>) pending news.</li>\n<li>Genocea's lead product candidate is GEN-003, a therapeutic vaccine for genital herpes. Positive results were achieved in a Phase 2 study.</li>\n<li>Arrowhead's lead product candidate is Phase 2-stage ARC-520, an RNAi therapeutic for the potential curative treatment of chronic hepatitis B infection.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211478\" data-linked=\"Trading in Genocea Bio and Arrowhead Pharma suspended pending news\" data-tweet=\"$GNCA $GNCA $ARWR - Trading in Genocea Bio and Arrowhead Pharma suspended pending news https://seekingalpha.com/news/3211478-trading-in-genocea-bio-and-arrowhead-pharma-suspended-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3211478-trading-in-genocea-bio-and-arrowhead-pharma-suspended-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211473\" data-ts=\"1475147785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEP\" target=\"_blank\">PEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211473-pepsico-buoyed-organic-growth-and-productivity-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PepsiCo buoyed by organic growth and productivity gains</a></h4><ul> <li>PepsiCo (NYSE:<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo Inc.\">PEP</a>) reports organic revenue increased 4.2% in FQ3. All of the company's segments showed positive organic revenue growth except Quaker Frito-Lay North America (-2%).</li> <li>Core gross margin rose 50 bps and core operating margin expanded 30 bps off of productivity improvements and lower raw materials costs.</li> <li>The core effective tax rate fell to 23.3% during the quarter, from 24.6% a year ago.</li> <li>PepsiCo expects EPS of $4.78 for the full year vs. $4.76 consensus and $4.71 prior. The food and beverage giant sees $3B in capital spending.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3211458-pepsico-beats-0_08-beats-revenue\" target=\"_blank\">PepsiCo beats by $0.08, beats on revenue</a> (Sept. 29)</li> <li>PEP <font color=\"green\">+2.53%</font> premarket to $110.10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211473\" data-linked=\"PepsiCo buoyed by organic growth and productivity gains\" data-tweet=\"$PEP - PepsiCo buoyed by organic growth and productivity gains https://seekingalpha.com/news/3211473-pepsico-buoyed-organic-growth-and-productivity-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3211473-pepsico-buoyed-organic-growth-and-productivity-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":55,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}